Enhanced Vaccine Immunogenicity Enabled by Targeted Delivery of Tumor Antigens into Dendritic Cells

Researchers

Departments: Department of Chemistry, Materials Science and Eng, Department of Biological Engineering
Technology Areas: Therapeutics: Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living

  • enhanced vaccine immunogenicity enabled by targeted delivery of tumor antigens into dendritic cells
    United States of America | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.